We used sodium dodecyl sulfate-polyacrylamide gel electrophoresis to study cyst fluids from women with breast gross cystic disease. The subjects could be classified into two categories according to the concentrations of protein GCDFP-70 in the cyst fluid: those with Type I cysts had a very low content of this protein; those with Type II cysts had very high concentrations. Analysis of the amino acid sequence of GCDFP-70 from both cyst fluid types confirmed that this protein is human plasma albumin. The average concentration of albumin found in Type I cyst fluids was 0.32 g/L and that corresponding to Type II was 10.16 g/L. Thus, albumin quantification from cyst fluids or analysis by either polyacrylamide or agarose gel electrophoresis provides a simple procedure for classifying these fluids, yielding results that correlate well with previous classifications based on other measurements such as sodium, potassium, and chloride concentrations. This albumin-based quantification method may improve the classification of breast cysts and might be useful in further studies on functional changes in the cysts and their relationship to breast cancer.
pausal women (1) . Although cystic lesions are only rarely precancerous, many studies in the last two decades (2) (3) (4) (5) (6) indicate that these patients are at about a fourfold greater risk of developing breast cancer than are control populations.
Because of the possibility that benign and malignant breast diseasehave some factors in common (7) , several studies have been carried out to type cysts in terms of the risk of further development of breast carcinoma. These studies have mainly been focused on determining the biochemical composition of cyst fluid. At present, data are available for the hormone content (8, 9) , ionic composition (9, 10) , enzyme activities (11) , and protein components (12) (13) (14) (15) . In addition, these analyses have revealed in cyst fluid in gross cystic disease the presence of four major protein components: GCDFP-70, -44, -24, Servicio de Medicina Nuclear, Hospital General de Asturias, Spain.
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and -15, proteins of respective molecular masses (in kilodaltons) corresponding to the numbers in the name. Some ofthese proteins have been studied with respect to their molecular characteristics and hormone binding properties. However, very little is known about their source, biological functions, or possible role in the induction of the pathological process characteristic of gross cystic breast disease. Recently, we have described how GCDFP-24, a progesterone-binding protein that accounts for more than half of the total protein present in cyst fluid, is apolipoprotein D, a component of high-density lipoproteins in human plasma, which are involved in cholesterol transport (16) . In the course of studies directed towards the characterization of this major component of cyst fluid, we found that the concentration of GCDFP-70 in cyst fluid from different patients varied widely. Several groups have tentatively characterized this protein as plasma albumin by using immunological analysis (12, 15, (17) (18) (19) , but no structural data to confirm this assignation are currently available. In addition, GCDFP-70 was present at concentrations 25-to 100-fold lower than that found for albumin in plasma (12, (17) (18) (19) .
The present work was aimed at evaluating breast cysts according to the content of GCDFP-70 as well as at providing further molecular characterization of this protein in the fluid filling the cysts. As we will show, we have identified GCDFP-70 as plasma albumin and established two categories of cysts on the basis of their concentration of this protein, which can be related to previous classifications of cysts based on ionic content, pH, glucose content, and cytological examination (9, (20) (21) (22) (23) . The possible relationship between cyst type and different functional stages of the epithelium lining the cysts are also discussed.
Materials and Methods
Samples. Forty-five cystfluidsamples were obtained, with informed consent, by needle aspiration from patients with gross cystic disease of the breast, ages 31 to 50 years. Cancer was excluded by clinical, echographic, mammographic, and cytological studies. All women had regular menstrual cycles, and none was taking any hormonal medication at the time of the study or during the preceding six months. Cystic fluid aspiration was carriedout in the mild luteal phase of the menstrual cycle, which was confirmed by measuring the concentrations of lutropin (luteinizing hormone), follitropin (follicle-stimulating hormone), and progesterone in blood samples. We quantified these hormones by immunoradiometric assay, using kits obtained from Ire-Medgenix Laemmli (25) . The proteins were stained with Coomassie Blue and in some cases with silver nitrate.
Agarose gel electrophoresis. The protein bands from different cyst fluids were separated by electrophoresis on agarose gel as described elsewhere (26) . The reagents and apparatus for electrophoresis were purchased from Corning Medical Ltd. (Halstead, U.K.).
Amino acid sequence analysis.
Samples containing about 0.5 nmol of protein were subjected to NH2-terminal analysisby sequential degradation on a Model 477A sequencer (Applied Biosystems, Foster City, CA) in the presence of Polybrene. The amino acid anilinothiazolinone derivatives were converted to phenylthiohydantomderivatives in the automated conversion flask of the sequencer and were identified and quantified with an on-line phenylthiohydantoin analyzer (Model 120A; Applied Biosystems) (27) . Direct sequencing of proteins separated by SDS-polyacrylamide gel electrophoresis was accomplished by blotting proteins onto a polyvinylidene difluoride membrane, staining them with Coomassie blue, and putting the membrane segment carrying the relevant protein directly into the sequencer (28).
Statistical
analysis. Student's t-test for unpaired data was performed to assess differences between the two groups of cysts. Correlation coefficients were calculated by the least-squares method. Significance was established at the 0.05 level.
Results

Evaluation of human breast cysts by SDS-polyacrylamide and agarose gel electrophoresis.
For shows, the chromatographic profiles differ clearlyin the region corresponding to an elution volume of about 50-51 mL. A major peak was detected at this position in fluids from Type II cysts but was practically absent in those fluids belonging to Type I cysts. Calibration of the column with serum albumin (data not shown) revealed the presence of a single peak eluting at the same volume. Analysis by SDS-polyacrylamide gel electrophoresis showed that fractions corresponding to these peaks contained a single band, the electrophoretic mo-I I mm.
The presence of the band corresponding to protein GCDFP-70 in the respective fractions of the chromatographic eluates from most of the Type I cyst fluids was visible only after prolonged silver staining of the polyacrylamide gels (Figure 3, inset) .
NH2-terminal sequence analysis of protein GCDFP-70 isolated from different cyst fluid types.
From the above resultsas well as from previous immunological data,it seems reasonable to assume that proteinGCDFP-70 is plasma albumin. However, in view of the recent discovery of the presence of active proteases in cyst fluid (29) , we considered it necessary to provide further characterization of the structure of the purified proteins. These studies would determine whether the proteins in cyst fluid show structural modifications as a consequence of proteolytic activities. Thus, purified GCDFP-70 from Type II cyst fluids was subjected to automated Edman degradation in a gas-liquid phase sequencer, which allowed the identification of the first 15 amino acid residues ( Table 1 ). The limited amount of GCDFP-70 available from Type I cyst fluids made the sequencing of its amino terminal very difficult. To overcome this problem, we blotted the electrophoretically separated proteins from this cyst fluid onto polyvinylidene difluoride filters before subsequent protein sequencing. These analyses allowed the identification of the first eight residues of GCDFP-70 from Type I cysts. In both cases the amino-terminal sequences were identical to that for human plasma albumin ( Table 1) .
Quantification of albumin concentrations in the different cyst fluids and correlation with other variables.
The classification of cysts on the basis of their GCDFP-70 content proposed above was based on visual estimation of the electrophoretic patterns of the different cysts. However, the discovery that GCDFP-70 is identical to plasma albumin made it possible to define accurately the concentrations of albumin that would correspond to each cyst subpopulation. To do so, we used a micromethod that allowed the automated determination of very low concentrations of albumin. As shown in Table 2 , the average concentration of albumin found in Type I cyst fluids was 0.32 gIL, whereas the value 
Discussion
Several studies performed by this group and others over the last few years have revealed the existence of distinctive patterns in the concentrations of different substances present in the cyst fluid of gross cystic disease of the breast (9, (20) (21) (22) (23) . However, no data are available for the classification of cysts on the basis of their protein composition. Here, on the basis of polyacrylamide and agarose gel electrophoresis analysis, we present evidence that cysts can be subdivided into different categories according to the concentrations of protein GCDFP-70.
In addition we confirm by amino acid sequence determinations that this protein is human plasma albumin.
The fact that women with breast gross cystic disease develop breast cancer with about four times the normally expected frequency has focused the attention of several laboratories on the evaluation of the possible relationship between the presence of specific substances in cyst fluid and the further development of breast carcinoma. As part of our studies directed towards the identification of potential markers for risk of breast cancer, we performed systematic analyses by polyacrylamide gel electrophoresis of the aspirated fluid from patients with breast gross cystic disease. Although these analyses allowed detection of the peculiar pattern of proteins described by several authors, a clear variation in the concentration of protein GCDFP-70 was easily detectable. The analysis of a large number of fluids, by either polyacrylamide or agarose gel electrophoresis, was useful to clearly establish two different subpopulations of cysts. Subsequent molecular characterization of GQDFP-70 isolated from the different cyst types showed that this intracystic protein is in all cases plasma albumin. (Table 2) .
From our results for albumin concentrations as well as from the above-described correlations with other previous classifications, we propose a preliminary hypothesis concerning the mechanisms of the development of breast cysts (31) (32) (33) . Type I cysts might represent an initial stage characterized by the activity of the apocrine epithelium that surrounds the cyst. The very low concentrations of albumin in these fluids would be the result of a high degree of impermeability to the extracellular fluid. On the other hand, Type II cysts could be the last stage of development, with the apocrine epithehum being flattened. The high concentrations of albumin found in these latter cysts could reflect a high degree of transudative phenomena and therefore more closely resemble the composition of extracellular fluid. The finding of some cyst fluids with albumin concentrations slightly higher than the mean values determined for Type I cysts or with lower concentrations than those established for Type II cysts might be indicative of the evolution of the breast cystic disease by passage from Type I to Type 11 (9) .
In summary, albumin quantification in cyst fluids provides a simple procedure for classifying them. Because several studies indicate that the natural history of breast disease varies according to the subtype of the cyst (6, 29) , the characterization of subgroups of patients with breast gross cystic disease may be of future clinical interest. From previous data, the risk of developing cancer would be greater in the apocrine cyst group, which corresponds to the Type I cysts with very low albumin concentrations. Further studies and clinical follow-up of patients belonging to different subgroups are in progress to evaluate the clinical significance of the use of albumin concentrations in cyst fluid as indicative of risk of epithelial proliferative changes, including breast carcinoma.
